Arrinex

Redwood City, United States Founded: 2013 • Age: 13 yrs Acquired By Stryker
Hand-held disposable cryotherapy devices for ENT procedures are developed.

About Arrinex

Arrinex is a Healthcare company based in Redwood City (United States) founded in 2013, and was acquired by Stryker in February 2019. Hand-held disposable cryotherapy devices for ENT procedures are developed. The company was acqui-hired. Its focus areas include Life Sciences, ENT Disorders, Medical Devices and Therapeutic Devices. Its competitors include Navage, NeilMed and Cogent Therapeutics; 1 of its 3 listed competitors has raised funding.

Company details

Arrinex was founded in 2013 and is based in Redwood City, United States. Non-invasive cryosurgical tools are developed by the company for surgical procedures, with a focus on ear, nose, and throat applications. The ClariFix device, a handheld disposable cryoballoon system, is used for targeted tissue ablation and received FDA 510(k) clearance in February 2017. A clinical study on chronic rhinitis patients has been completed using this device.

  • Headquarters Redwood City, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website arrinex.com
  • Social LinkedIn Facebook
  • Acquired by Stryker (Feb 2019)
Operational Areas
Key Metrics

Investors in Arrinex

Arrinex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Stryker.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
3D-printed orthopedic products are manufactured for medical applications.
1941stryker.comKalamazoo, United States
Premium access

Investor details for Arrinex

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Arrinex

2 dated milestones of Arrinex across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Arrinex is founded.
  2. Exit Acquired by Stryker.

Competitors of Arrinex

Arrinex has 3 listed competitors in our database, 1 of them funded. They include Navage, NeilMed and Cogent Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
navage.com2007Broadview Heights, United States$19.06M
Nasal irrigator that uses suction
neilmed.com2000Santa Rosa, United States
Manufactures nasal irrigation systems for sinus and allergy relief worldwide.
cogent-tx.com2011Hayward, United States
Develops biopolymer solutions for nasal and ENT applications.
Premium access

Detailed competitors of Arrinex

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in ENT Disorders

3 companies that operate in the same segment as Arrinex (ENT Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medicines are developed to protect, repair, and restore hearing capacity.
2015Cambridge, Massachusetts, United StatesUSD 169.53 M62
Small molecule therapeutics for ENT diseases are developed.
2005Watertown, United StatesUSD 127.61 MUSD 1.53 M30
Hearing aids are supplied for individuals with hearing disabilities.
2010San Jose, California, United StatesUSD 216.58 M45
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Arrinex

Stryker Acquires Arrinex
Cmocro β€’ 7 years ago
Premium access

Complete news archive for Arrinex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arrinex

Arrinex was founded in 2013.

Arrinex is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

Arrinex was founded in 2013 and is based in Redwood City, United States. Non-invasive cryosurgical tools are developed by the company for surgical procedures, with a focus on ear, nose, and throat applications. The ClariFix device, a handheld disposable cryoballoon system, is used for targeted tissue ablation and received FDA 510(k) clearance in February 2017. A clinical study on chronic rhinitis patients has been completed using this device.

Arrinex's top competitors include Navage, NeilMed and Cogent Therapeutics.

Arrinex has 1 investor. Key investors include Stryker.

Yes. Arrinex was acquired by Stryker in February 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available